Drug Executive Collapses During Oval Office Press Conference
During a press conference in the Oval Office, a drug executive fainted while President Donald Trump announced a deal with pharmaceutical companies to lower obesity drug prices. The event was cut short as the executive, identified as Gordon Findlay, global brand director for Novo Nordisk, collapsed.
Details of the Incident
David Ricks, CEO of Eli Lilly, noticed the collapse and asked,
“Are you okay? Gordon, are you okay?”Dr. Mehmet Oz quickly intervened as Findlay fell to his knees. The press was then asked to leave the room.
Context of the Announcement
The press conference focused on an agreement involving President Trump and drugmakers Eli Lilly and Novo Nordisk to expand insurance coverage and reduce prices for obesity treatments Zepbound and Wegovy.
Aftermath and Update
Health and Human Services Secretary was present during the incident. Approximately 30 minutes later, the conference resumed, and President Trump provided an update on Findlay's condition.
“President Donald Trump looks on as Administrator for the Centers for Medicare & Medicaid Services Dr. Mehmet Oz and others help Gordon Findlay of Novo Nordisk, who passed out during an event where Trump spoke on lowering drug prices.”
Author's summary: A sudden collapse of a drug executive during a high-profile drug price announcement led to an interruption, with quick medical response and a later update on his health by President Trump.